Tech Transfer Support: Choosing Cap Components that Simplify CMO Scale-Up

Scaling an injectable from pilot to commercial at a CMO is rarely blocked by formulation alone. A lot of “surprises” happen at the last meters of the line: stopper placement, cap feeding, crimping, inspection, and container closure integrity (CCI).

For a Tech Transfer Manager, the goal is simple: deliver a closure setup that runs the same way on different capper models, different shifts, different sites, with a data package that QA can defend.

One reminder before diving in: EMA Pharma manufactures aluminum overseals (crimp caps, flip-off, tear-off, push-off). Rubber stoppers are a different supply stream and touch the drug; overseals do not. Still, the overseal and the capping process can make or break CCI, so they belong in your tech transfer scope.

1) Start with the scale-up constraints, not the catalog

A cap that “works in R&D” can fail at the CMO for three repeatable reasons:

A. Annex 1 finishing expectations at the capping step

EU GMP Annex 1 is explicit: if capping is performed outside the aseptic processing area, stoppered vials should be protected with a Grade A air supply until the cap has been crimped (with background at least Grade D). It also calls out stopper-height detection when capping is done as a clean process with Grade A air supply.

That drives immediate component choices:

• sterile caps vs clean caps + in-house sterilization
• packaging format compatible with isolators/RABS
• particle generation at the capper (and extraction design)
  
  

B. Your CCIT strategy (deterministic beats “legacy comfort”)

USP’s package integrity chapter frames CCI as a structured program for sterile products and container-closure systems.
If your tech transfer package still relies on a single probabilistic method, expect questions during PPQ, site validation, or audits.

C. Equipment variability across CMOs

Different cappers, tooling wear, and line speeds change how the stopper is compressed under the cap. Scale-up gets easier when you define:

• a measurable “good seal” window
• a way to compare settings across machines

That’s where Residual Seal Force (RSF) becomes a strong bridge metric.

2) Pick the cap format that matches the CMO’s aseptic architecture

Think of cap format as a cleanroom logistics decision as much as a product decision.

Option 1 - Ready-to-be-sterilized (RTS): best when the CMO owns steam cycles

RTS caps are intended to enter controlled environments and go through steam sterilization at the site.
Use RTS when:

• the CMO has qualified cycles and load patterns
• your program accepts site-to-site sterilization variability (with controls)
  
  

Option 2 - Ready-to-be-used (RTU): best when you want to remove sterilization as a variable

EMA Pharma describes RTU caps as cleaned to low particle/bioburden levels, double-packed in heat-sealed PE bags, then sterilized by ionizing radiation in final packaging, with a validated process and shelf-life stated as more than 3 years.
RTU fits well when:

• capping is inside the aseptic core or tight Grade A protection is required
• you need faster tech transfer with fewer site-specific sterilization steps
  
  

Option 3 - RTP / isolator transfer packaging: best when the CMO runs isolators

EMA Pharma lists RTP (Rapid Transfer Port) bags for direct introduction to isolators as an available packaging format.
Choose this early if the receiving CMO is isolator-first, because it impacts:

• bag dimensions and transfer hardware
• material compatibility (VHP exposure, handling constraints)
• line-side ergonomics (feeders, depalletizing, staging)
  
  

3) Lock the “geometry and usability” decisions that cause scale-up churn

A. Neck finish and diameter matching

Your cap must match vial standards used at the CMO (common sizes include 13 mm, 20 mm, 32 mm, etc.). EMA’s crimp cap guide references these standard neck sizes and typical aluminum shell construction.

B. Access design: center hole, center tab, tear-off, flip-off/push-off

EMA’s aluminum cap range includes:

• center hole (immediate access to the stopper injection site)
• center tab (protects the injection site with a removable aluminum tab)
• complete tear-off (full removal for access or sorting needs)
• combined aluminum/plastic push-off (tamper evidence through non-reversible lid removal)

Tech transfer tip: opening force and user steps matter more at commercial scale than teams expect. If your program includes hospital handling, clinical sites, or patient-facing use, choose the access concept before PPQ so you don’t re-validate downstream.

C. Standards that procurement and QA will ask about

For aluminum caps and aluminum/plastic caps used on infusion bottles and injection vials, ISO references include:

• ISO 8872:2022 (general requirements and test methods)
• ISO indicates ISO 10985:2009 is withdrawn and replaced by ISO 8872:2022
• ISO 15378:2017 (quality management for primary packaging materials with GMP references) and a 2024 climate-action amendment

Even if an overseal does not contact the drug, your quality narrative improves when your supplier can map product specs and controls to these references.

4) Make the capping process transferable with RSF and stopper-height controls

A. Use RSF to “standardize” seal quality across machines

PDA training material defines RSF as the force a compressed elastomeric stopper flange continues to exert on the vial sealing surface after crimping and positions it as a quantitative way to standardize seal quality regardless of capping equipment.

Two practical rules for tech transfer:

• RSF is not a leak test. Treat it as a process metric that must be correlated with your CCIT method(s).
• Define a permissible lower RSF limit (and upper bound if needed) based on data, not “tribal settings.” PDA literature describes statistical approaches to establish limits with confidence.

B. Don’t ignore stopper-height detection: Annex 1 makes it an expectation

Annex 1 states that when capping is a clean process under Grade A air supply protection, vials with missing or displaced stoppers should be rejected prior to capping, and automated methods for stopper-height detection should be in place.

For tech transfer, that means:

• document the reject threshold rationale (height vs CCI risk)
• verify the sensor performance during engineering runs
  
  
• align with the CMO’s inspection platform (and how it trends false rejects)

(Useful industry discussion exists on correlating stopper height to CCI risk, including vendor guidance that explicitly references Annex 1 §8.28.)

C. Control particle generation at the capper

Annex 1 flags that crimping equipment can generate large quantities of non-viable particles and calls for measures like physical separation and adequate extraction.
If your CMO struggles with particle excursions, cap choice alone won’t save you—your transfer package should include capper station design notes.

5) Build a Tech Transfer Support “data pack” your CMO can execute

Here’s a checklist you can hand over as a single deliverable.

A. Component definition pack (what the CMO must receive)

• Cap drawing/specs (diameter, skirt length, lacquer system, color coding)
• Packaging format spec (RTS/RTU/RTP; bag count; heat-seal; labeling)
• Handling instructions (cleanroom opening steps, staging limits)
• Certificates expected per lot (CoC/CoA, irradiation cert for RTU when applicable)

EMA’s RTU description includes double PE bagging and gamma sterilization in final packaging, which is exactly the type of process detail a CMO needs in a transfer file.

B. Process window pack (how the CMO must run it)

• Capper model(s) and tooling assumptions
• Target settings ranges (not a single point): head height, force, speed
• RSF target window + sampling plan + correlation to CCIT
• Stopper-height detection: setpoints, qualification approach, reject logic
• Defect library with accept/reject criteria aligned to your QRM file

C. Lifecycle pack (how changes will be controlled)

• supplier change notification and technical change control expectations
• complaint trending signals (RSF drift, cap deformation patterns, rejects)
• transport/shipping risk assessment for CCI (Annex 1 calls this out)

EMA’s supplier-selection blog highlights DMF filings (US and China) and points to the need for irradiation validation and certificates for RTU caps, plus change control expectations, these items fit directly into lifecycle planning.

6) What “tech transfer support” should mean from a cap supplier

When you evaluate or brief a supplier, ask for support in five buckets:

1. Aseptic logistics fit
   RTS vs RTU vs RTP, packaging drawings, transfer steps, validation references.
2. Documentation depth
   ISO 15378 positioning, lot traceability, CoC/CoA practices.
3. Capping science support
   Guidance on settings, defect mechanisms, RSF/CCI correlation planning (even if the CMO runs the studies).
4. Regulatory readiness
   DMF support when relevant, clear statements on what the overseal does and does not contact, plus a clean separation from elastomer/stoppers responsibilities.
5. Scale continuity
   Sample-to-commercial continuity, validated inspection approach, consistent assembly environment and contamination controls.

EMA’s service pages describe “EMA CLEAN-CAPS” and their positioning for low particulate/bioburden levels and readiness for controlled environments, which aligns with what tech transfer teams need to remove late surprises.

FAQ

Does an aluminum crimp cap count as primary packaging?
The cap does not contact the drug, but it is part of the container-closure system that protects sterility and CCI. USP’s integrity chapter explicitly addresses container-closure systems for sterile products.

When should a program choose RTU caps?
When you want to remove site sterilization variability and bring a double-packed, gamma-sterilized component into the aseptic area. EMA describes RTU caps as double-packed and sterilized by ionizing radiation in final packaging with a validated process and a stated shelf life of more than 3 years.

What does Annex 1 say about capping outside the aseptic area?
Annex 1 allows capping as a clean process outside the aseptic processing area, with Grade A protection for stoppered vials via Grade A air supply until crimping, plus stopper-height detection expectations.

Is RSF enough to prove container closure integrity?
RSF is a quantitative process metric tied to stopper compression. It should be correlated with validated CCIT methods and used to keep the process in control during scale-up and routine manufacture.